Cargando…
Changes of colistin pharmacokinetics in critically ill patients due to the extracorporeal membrane oxygenation: protocol for the COL-ECMO2022 trial – a prospective, non-randomised, open-label phase IV pharmacokinetic clinical trial
INTRODUCTION: Colistin is a lipopeptide antibiotic administered as an inactive prodrug—colistin methanesulfonate (CMS). Colistin is a drug with a narrow therapeutic window; the limiting factors are mainly nephrotoxicity and neurotoxicity, dependent on plasma concentrations. The number of patients wi...
Autores principales: | Suk, Pavel, Rychlíčková, Jitka, Součková, Lenka, Kubíčková, Vendula, Urbánek, Karel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387630/ https://www.ncbi.nlm.nih.gov/pubmed/37518089 http://dx.doi.org/10.1136/bmjopen-2023-071649 |
Ejemplares similares
-
Challenges of Colistin Use in ICU and Therapeutic Drug Monitoring: A Literature Review
por: Rychlíčková, Jitka, et al.
Publicado: (2023) -
Protocol for a multicentre randomised controlled trial evaluating the effects of moderate hypothermia versus normothermia on mortality in patients with refractory cardiogenic shock rescued by venoarterial extracorporeal membrane oxygenation (VA-ECMO) (HYPO-ECMO study)
por: Jacquot, Audrey, et al.
Publicado: (2019) -
Population Pharmacokinetics of Prophylactic Cefazolin in Cardiac Surgery with Standard and Minimally Invasive Extracorporeal Circulation
por: Šantavý, Petr, et al.
Publicado: (2022) -
Dosing of Extracorporeal Cytokine Removal In Septic Shock (DECRISS): protocol of a prospective, randomised, adaptive, multicentre clinical trial
por: Kanjo, Anna, et al.
Publicado: (2021) -
Restrictive versus Liberal Rate of Extracorporeal Volume Removal Evaluation in Acute Kidney Injury (RELIEVE-AKI): a pilot clinical trial protocol
por: Murugan, Raghavan, et al.
Publicado: (2023)